| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Technical Officer | SVP, Chief Technical Officer
1 company
Labarre Michael J. is a SVP, Chief Technical Officer at HALOZYME THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $12.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 12,000 | $38.76 | $465,176.09 | -4.1% | |
| Oct 20, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 12,000 | $30.43 | $365,148.00 | -7.6% | |
| Sep 21, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 12,000 | $26.91 | $322,884.00 | -7.0% | |
| Aug 20, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 12,000 | $28.30 | $339,564.00 | -6.6% | |
| Jul 20, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sell | 12,000 | $29.01 | $348,072.00 | -6.2% | |
| May 20, 2020 | HALO Halozyme Therapeutics, Inc. | SVP, Chief Technical Officer | Sale+OE | 21,387 | $23.80 | $509,074.76 | -10.8% |